Piggyback Sulcoflex Toric IOL for Correcting Refractive Error Following Corneal Transplantation

Sponsor
Rabin Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01718184
Collaborator
Einat Medical Inc. (Industry)
25
1
1
24
1

Study Details

Study Description

Brief Summary

A prospective study to evaluate the safety and efficacy of a piggyback sulcoflex toric intraocular lens in pseudophakic patients for correcting refractive errors following corneal transplantation

Condition or Disease Intervention/Treatment Phase
  • Procedure: toric intraocular lens implantation
  • Procedure: Sulcoflex intraocular lens implantation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date :
Oct 1, 2012
Anticipated Primary Completion Date :
Apr 1, 2014
Anticipated Study Completion Date :
Oct 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sulcoflex

Sulcoflex intraocular lens implantation

Procedure: toric intraocular lens implantation
piggyback Sulcolflex toric intraocular lens implantation

Procedure: Sulcoflex intraocular lens implantation

Outcome Measures

Primary Outcome Measures

  1. Best corrected and uncorrected visual acuity [3 month]

    Best corrected and uncorrected visual acuity following the IOL implantation

Secondary Outcome Measures

  1. Ocular complications [3 months]

    pigmentary dispersion, iris bulging, inter lenticular opacifications, lens decentration

Other Outcome Measures

  1. Refractive outcomes [3 months]

    refractive outcomes following surgical intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • after corneal transplantation with refractive errors

  • after cataract removal and intraocular lens implantation

Exclusion Criteria:
  • other ophthalmologic disorders limiting vision including glaucoma, AMD, profound amblyopia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rabin Medical Center Petah Tiqwa Israel

Sponsors and Collaborators

  • Rabin Medical Center
  • Einat Medical Inc.

Investigators

  • Principal Investigator: Irit Bahar, MD, Rabim Medical Center, Israel

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT01718184
Other Study ID Numbers:
  • RabinMC Sulcoflex Toric IOL
First Posted:
Oct 31, 2012
Last Update Posted:
Oct 31, 2012
Last Verified:
Jul 1, 2012
Keywords provided by Rabin Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2012